Institutul Clinic Fundeni, Bucarest, Romania Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT02372357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Institutul Clinic Fundeni | Institutul Clinic Fundeni Bucharest

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 6